Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Josh Sullivan
josh@endpointsnews.com
author articles
Covid-19 roundup: AstraZeneca vaccine halted in Germany for below-60 population; Pfizer says Covid-19 vaccine has ...
5 years ago
Coronavirus
Recall report: Zydus recalls herpes drug after crystallization complaints; Alembic pulls low blood pressure drug for ...
5 years ago
Manufacturing
Novartis dives even deeper into radioligands, notching licensing deal with iTheranostics for multiple compounds
5 years ago
Deals
Covid-19 roundup: Moderna passes 100M mark for US vaccines in landmark moment; Fake Pfizer vaccine found in Mexico
5 years ago
R&D
Coronavirus
With $190M in investor cash to play with, China's Chime Biologics looks to build 15x manufacturing capacity by 2024
5 years ago
Deals
Manufacturing
Covid-19 roundup: Cuomo administration allegedly gave Regeneron's George Yancopoulos special preference for testing ...
5 years ago
Coronavirus
Chinese CDMO Raybow quadruples workforce at NC site, hoping to help build next biopharma manufacturing hub
5 years ago
R&D
Manufacturing
Novartis walks away from 3rd Zolgensma plant just a year after leasing it as it pivots resources to next-gen pipeline
5 years ago
Pharma
Manufacturing
Covid-19 manufacturing roundup: AstraZeneca denies stockpiling claims; Virchow Biotech to make Sputnik V vaccine in ...
5 years ago
Manufacturing
Covid-19 roundup: India halts AstraZeneca vaccine exports as in-country cases rise — report
5 years ago
Coronavirus
T cell therapy player Lyell prepares to open $65M manufacturing facility in the Seattle area
5 years ago
Manufacturing
In a first for upstart synthetic biology field, Zymergen files for $100M IPO
5 years ago
Financing
Hoping to take drug R&D into the cloud, Insightful Science snaps up data management outfit Dotmatics
5 years ago
Deals
R&D
Takeda takes a swing at RNA small molecules with discovery pact for multiple potential Evotec programs
5 years ago
Deals
R&D
First page
Previous page
26
27
28
29